HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C M Croce Selected Research

fragile histidine triad protein

11/2001Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
5/2001Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression.
10/2000Expression of Fhit protein during mouse development.
4/2000Muir-Torre-like syndrome in Fhit-deficient mice.
3/2000Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C M Croce Research Topics

Disease

52Neoplasms (Cancer)
01/2017 - 02/2000
7B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2017 - 01/2010
7Carcinogenesis
02/2012 - 02/2000
6Leukemia
10/2016 - 02/2000
6Carcinoma (Carcinomatosis)
01/2016 - 02/2000
5Lung Neoplasms (Lung Cancer)
03/2020 - 07/2000
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2016 - 02/2000
4Lymphoma (Lymphomas)
12/2011 - 04/2000
3Melanoma (Melanoma, Malignant)
01/2015 - 02/2000
3Glioblastoma (Glioblastoma Multiforme)
08/2013 - 09/2005
3Breast Neoplasms (Breast Cancer)
03/2011 - 02/2000
2Acute Promyelocytic Leukemia
06/2022 - 06/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021 - 06/2008
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2015 - 02/2000
2Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 02/2000
2Infections
08/2013 - 05/2006
2Glioma (Gliomas)
08/2013 - 02/2012
2Esophageal Neoplasms (Esophageal Cancer)
10/2012 - 02/2001
2Chromosome Aberrations (Chromosome Abnormalities)
10/2006 - 02/2001
2Hematologic Neoplasms (Hematological Malignancy)
08/2000 - 04/2000
1Mitochondrial Diseases (Mitochondrial Disease)
10/2016
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2014
1T-Cell Lymphoma (Lymphoma, T Cell)
11/2014
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2014
1Alopecia (Baldness)
07/2014
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
07/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2014
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2014
1Squamous Cell Carcinoma of Head and Neck
02/2014
1Neoplasm Metastasis (Metastasis)
08/2013
1Prostatic Neoplasms (Prostate Cancer)
08/2013
1Hepatitis C
01/2013
1Inflammation (Inflammations)
10/2012
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2011
1Burkitt Lymphoma (Burkitt's Lymphoma)
12/2011
1Epstein-Barr Virus Infections
12/2011
1Liver Neoplasms (Liver Cancer)
11/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
09/2011

Drug/Important Bio-Agent (IBA)

28MicroRNAs (MicroRNA)IBA
06/2022 - 09/2005
20Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2000
7DNA (Deoxyribonucleic Acid)IBA
07/2011 - 02/2000
6Histidine (L-Histidine)FDA Link
05/2006 - 02/2001
5CarcinogensIBA
10/2012 - 04/2000
5fragile histidine triad proteinIBA
11/2001 - 03/2000
4Pharmaceutical PreparationsIBA
10/2016 - 12/2010
4Messenger RNA (mRNA)IBA
02/2014 - 08/2000
3Biological ProductsIBA
01/2017 - 02/2001
3CytokinesIBA
10/2014 - 10/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2013 - 06/2008
3nitrosobenzylmethylamineIBA
10/2012 - 08/2001
2Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2022 - 06/2007
2Tyrosine (L-Tyrosine)FDA Link
03/2020 - 05/2006
2SurvivinIBA
03/2020 - 05/2006
2Histones (Histone)IBA
01/2017 - 04/2016
2Monoclonal AntibodiesIBA
07/2014 - 04/2000
2AgarIBA
08/2013 - 02/2012
2Caspase 3 (Caspase-3)IBA
08/2013 - 06/2000
2LigandsIBA
08/2013 - 12/2010
2Estrogen ReceptorsIBA
09/2011 - 03/2011
2Complementary DNA (cDNA)IBA
09/2011 - 01/2007
2Hormones (Hormone)IBA
09/2011 - 03/2011
2AphidicolinIBA
05/2001 - 08/2000
2Peptides (Polypeptides)IBA
06/2000 - 03/2000
2Environmental CarcinogensIBA
03/2000 - 02/2000
1Lysine (L-Lysine)FDA Link
01/2017
1UbiquitinIBA
01/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
10/2016
1Fatty Acids (Saturated Fatty Acids)IBA
10/2016
1PerhexilineIBA
10/2016
1Carnitine (L-Carnitine)FDA LinkGeneric
10/2016
1Protein SIBA
04/2016
1Arginine (L-Arginine)FDA Link
04/2016
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
04/2016
1Interleukin-10 (Interleukin 10)IBA
01/2016
1pevonedistatIBA
10/2015
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
10/2015
1NF-kappa B (NF-kB)IBA
08/2014
1human HMGA2 proteinIBA
07/2014
1naratuximab emtansineIBA
07/2014
1TetraspaninsIBA
07/2014
1Immunoconjugates (Immunoconjugate)IBA
07/2014
1Rituximab (Mabthera)FDA Link
07/2014
1Tumor Biomarkers (Tumor Markers)IBA
02/2014
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2014
1Caspase 7IBA
08/2013
13' Untranslated Regions (3' UTR)IBA
08/2013
1Chemokine ReceptorsIBA
10/2012
1ZincIBA
10/2012
1CC ChemokinesIBA
10/2012
1Phosphates (Orthophosphate)IBA
02/2012
1Long Noncoding RNAIBA
11/2011
1WW Domain-Containing OxidoreductaseIBA
09/2011
1Progesterone Receptors (Progesterone Receptor)IBA
09/2011
1HMGA ProteinsIBA
07/2011
1Ataxia Telangiectasia Mutated ProteinsIBA
07/2011
1Estrogen Receptor Modulators (Antiestrogen)IBA
03/2011
1Fulvestrant (Faslodex)FDA Link
03/2011

Therapy/Procedure

11Therapeutics
07/2014 - 02/2001
2Aftercare (After-Treatment)
08/2001 - 02/2000